Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study
Ashina, Messoud, Cohen, Joshua M., Galic, Maja, Campos, Verena Ramirez, Barash, Steve, Ning, Xiaoping, Kessler, Yoel, Janka, Lindsay, Diener, Hans-Christoph
Published in Journal of headache and pain (01.12.2021)
Published in Journal of headache and pain (01.12.2021)
Get full text
Journal Article
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (24.11.2021)
Published in Journal of headache and pain (24.11.2021)
Get full text
Journal Article
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Nahas, Stephanie J., Naegel, Steffen, Cohen, Joshua M., Ning, Xiaoping, Janka, Lindsay, Campos, Verena Ramirez, Krasenbaum, Lynda J., Holle-Lee, Dagny, Kudrow, David, Lampl, Christian
Published in Journal of headache and pain (17.05.2022)
Published in Journal of headache and pain (17.05.2022)
Get full text
Journal Article
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
McAllister, Peter, Cohen, Joshua M., Campos, Verena Ramirez, Ning, Xiaoping, Janka, Lindsay, Barash, Steve
Published in Journal of headache and pain (29.08.2022)
Published in Journal of headache and pain (29.08.2022)
Get full text
Journal Article
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Ferrari, Michel D, Diener, Hans Christoph, Ning, Xiaoping, Galic, Maja, Cohen, Joshua M, Yang, Ronghua, Mueller, Matthias, Ahn, Andrew H, Schwartz, Yael Carmeli, Grozinski-Wolff, Melissa, Janka, Lindsay, Ashina, Messoud
Published in The Lancet (British edition) (21.09.2019)
Published in The Lancet (British edition) (21.09.2019)
Get full text
Journal Article
085 Medication overuse reversion following fremanezumab treatment in migraine patients with inadequate response to prior preventives
Ashina, Sait, Campos, Verena Ramirez, Cohen, Joshua, Janka, Lindsay, Krasenbaum, Lynda, Blume, Lydia
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.09.2022)
Get full text
Journal Article
054 Tolerability of fremanezumab in migraine patients with cardiovascular medica- tion use at baseline: a pooled analysis
Coppola, Gianluca, Cohen, Joshua, Ning, Xiaoping, Kessler, Yoel, Janka, Lindsay, Riaz, Sajjad, Barbanti, Piero
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2022)
Published in Journal of neurology, neurosurgery and psychiatry (01.06.2022)
Get full text
Journal Article
Reversion from medication overuse with fremanezumab treatment in patients with inadequate response to multiple migraine preventive medication classes
Ashina, Sait, Campos, Verena Ramirez, Cohen, Joshua, Janka, Lindsay, Krasenbaum, Lynda J.
Published in Journal of the neurological sciences (01.10.2021)
Published in Journal of the neurological sciences (01.10.2021)
Get full text
Journal Article
Efficacy and tolerability of fremanezumab for migraine preventive treatment in Korean patients with chronic or episodic migraine
Kim, Byung-Kun, Cohen, Joshua, Kim, Sukyung, Chang, Daeho, Ning, Xiaoping, Lengil, Tamar, Janka, Lindsay, Barash, Steve
Published in Journal of the neurological sciences (01.10.2021)
Published in Journal of the neurological sciences (01.10.2021)
Get full text
Journal Article
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
Silberstein, Stephen D., McAllister, Peter, Ning, Xiaoping, Faulhaber, Nicola, Lang, Nicole, Yeung, Paul, Schiemann, Jimmy, Aycardi, Ernesto, Cohen, Joshua M., Janka, Lindsay, Yang, Ronghua
Published in Headache (01.06.2019)
Published in Headache (01.06.2019)
Get full text
Journal Article
Bioequivalence of cyclobenzaprine hydrochloride extended-release capsule taken intact or sprinkled over applesauce
Adar, Liat, Zarycranski, William, Conner, Jill B, Dragone, Jeffrey, Janka, Lindsay, Rabinovich-Guilatt, Laura
Published in International journal of clinical pharmacology and therapeutics (01.12.2017)
Published in International journal of clinical pharmacology and therapeutics (01.12.2017)
Get full text
Journal Article